Research article Open access
Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
Purpose: To evaluate the safety and efficacy of 0.003% tacrolimus suspension for the treatment of refractory vernal keratoconjunctivitis (VKC). Materials and methods: This prospective study included 40 eyes of 20 patients with severe VKC. After discontinuing all other medications, patients were treated with varying dos …